Replies to post #62712 on Regen BioPharma Inc (RGBP)

[soupoftheday]

5 YEARS AGO...Regen BioPharma, Inc. (OTCQB: RGBP), (OTCQB: RGBPP), announced today submission to the Food and Drug Administration (FDA) of a revised Investigational New Drug (IND) application focused on using a novel method to unleash the body's innate ability to kill cancer.

https://www.biospace.com/article/releases/regen-biopharma-responds-to-fda-on-dcellvax-gene-silenced-breast-cancer-immunotherapy-/

[soupoftheday]

The US FDA cleared HemaXellerate to conduct phase I/ II clinical studies.
https://drpgazette.com/2021/05/09/regen-biopharma-inc-otcmkts-rgbp-quickly-becomes-the-darling-in-small-caps-and-commands-a-volume-of-50-million/